Product description

Butatron is a synthetic, non-hormonal, anti-inflammatory for dogs and horses.

Active ingredients

Each tablet of Butatron contains:

• Phenylbutazone U.S.P. 1 g

Indications for use

Butatron Phenylbutazone possesses non-hormonal, anti-inflammatory activity of value in the management of musculoskeletal conditions in dogs and horses such as the arthritides, including osteoarthritis, and as an aid in the relief of inflammation associated with intervertebral disc syndrome in dogs.

Administration and dosage

Butatron administration:

• Use a relatively high dose for the first 48 hours, then reduce gradually to a maintenance dose. Maintain lowest dose capable of producing the desired clinical response.
• In many cases tablets may be crushed and given with feed. Reduce the dosage as symptoms regress. In some cases treatment may be given only when symptoms appear with no need for continuous medication.
• In animals, phenylbutazone is largely metabolized in 8 hours. It is recommended that a third of the daily dose be administered at 8 hour intervals.
• Many chronic conditions will respond to phenylbutazone therapy but discontinuance of treatment may result in the recurrence of symptoms.

Dogs:

• Oral administration.
• 20 mg per pound body weight (100 mg/5 lbs.) daily in 3 divided doses, not to exceed 800 mg daily regardless of body weight.

Horses:

• Oral administration.
• 1-2 grams per 500 lbs. body weight, not to exceed 4 grams daily.

Prescribing information